A NEW MODEL FOR COLLABORATIVE CLINICAL RESEARCH
IN ONCOLOGY

WE ARE AN INTERNATIONAL, INNOVATIVE, RESEARCH ORGANIZATION IN CLINICAL ONCOLOGY. OUR GOAL IS TO GENERATE THE MOST INNOVATIVE CLINICAL TRIALS WITH THE MOST PROMISING DRUGS BY FOSTERING GLOBAL COLLABORATIONS BETWEEN EXPERT CLINICAL INVESTIGATORS/KOLs AND PHARMACEUTICAL COMPANIES/BIOTECHS.

WE CONNECT THE BEST TREATMENTS WITH THE BRIGHTEST MINDS

MEDSIR is a company founded by scientific experts in 2012. We are dedicated to the design and management of strategic clinical trials in oncology, from study conception to the publication of study results.

MEDSIR favors a new model for collaborative clinical research in oncology development that aims to combine the highest scientific value with the strategic development of novel cancer treatments, with the final goal of benefiting cancer patients worldwide. Our goal is to generate win-win scenarios for all stakeholders involved in independent clinical research.

TOGETHER WE CAN BUILD A BRIGHTER FUTURE

MEDSIR ONCOCLÍNICAS ACADEMY

MEDSIR and Oncoclínicas & Co. teamed up to launch the MEDSIR Oncoclínicas Academy, an educational project aiming to elevate clinical research expertise globally. In the past edition, a group of Medical Oncologists specialized in breast cancer from Brazil, attended a 5-day program in Barcelona, Spain.

The hands-on experience in a hospital and the workshops led by experts and KOLs, resulted in an increase of the group’s expertise in the design and management of clinical trials, offering both a scientific and operational perspective while delineating their roles and responsibilities as Principal Investigators.

WHAT WE DO

Our international team of high-level clinicians and research experts are passionate about collaborating with medical oncologists and pharmaceutical companies to develop the best treatments for patients as quickly as possible.